VEGFA and neoplasm: Recombinant human endostatin (Endostar), an angiogenesis inhibitor, has shown the effect of downregulating transplantation matrix metalloproteinases (MMP) and vascular endothelial growth factor (VEGF) to inhibit neovascularization and tumor growth5.